Hipotez Testi Çalışmalarında Örneklem Büyüklüğü Hesaplamanın Mantığı
Synopsis
Hipotez testi çalışmalarında örneklem büyüklüğü belirleme süreci, temel olarak istatistiksel güç kavramına dayanmakta ve araştırmanın güvenilirliğini doğrudan etkilemektedir. Önem seviyesi (α), hedeflenen güç (1-β) ve saptanabilir minimum fark gibi parametrelerin doğru kararlaştırılması, müdahalenin etkisini bilimsel olarak kanıtlamak için kritik bir öneme sahiptir. Tek ve iki örneklem t-testleri için geliştirilen spesifik formüller aracılığıyla, popülasyon varyansı ve test tipine bağlı olarak ideal denek sayısı matematiksel yöntemlerle hesaplanabilmektedir.
Sample size determination in hypothesis testing studies is fundamentally based on the concept of statistical power and directly affects the reliability of the research. Accurate decision-making regarding parameters such as significance level (α), target power (1-β), and minimum detectable difference is critical for scientifically proving the effect of an intervention. Through specific formulas developed for one-sample and two-sample t-tests, the ideal number of subjects can be calculated using mathematical methods depending on population variance and test type.
References
Betz MA, Gabriel KR. Type IV errors and analysis of simple effects. Journal of Educational Statistics. 1978;3(2): 121–143.
Chow SC, Shao J, Wang H. Sample size calculations in clinical research. Chapman & Hall/CRC; 2008.
Ellis P. The essential guide to effect sizes: Statistical power, meta-analysis, and the interpretation of research results. New York: Cambridge University Press; 2010. ISBN 978-0521142465.
Erdfelder E, Faul F, Buchner A. Power analysis for categorical methods. ‘B. S. Everitt,D. C. Howell’ (Eds.). İn Encyclopedia of statistics in behavioral science. Chichester: Wiley; 2005. p. 1565–1570
Hern RP. Sample size tables for exact single–Stage phase II designs. Statistics in Medicine. 2001;20(6):859–866.
Julious SA. Tutorial in biostatistics: Sample size for clinical trials. Statistics in Medicine. 2004; 23(12): 1921–1986.
Julious SA. Sizes for clinical trials. Chapman & Hall/CRC, 2009.
Julious SA, Campbell MJ. Tutorial in biostatistics: Sample size for parallel group clinical trials with binary data. Statistics in Medicine. 2010; 31(24): 2904–2936.
Krzywinski M, Altman N. Points of significance: Power and sample size. Nature Methods. 2013; 10(12): 1139–1140.
Lenth RV. Some practical guidelines for effective sample size determination. American Statistician. 2001;55(3):187–193.
Muller KE, Benignus VA. Increasing scientific power with statistical power. Neurotoxicology and Teratology. 1992; 14(3): 211–219.
Muller KE, Lavange LM, Ramey SL, et al. Power calculations for general linear multivariate models including repeated measures applications. Journal of American Statistical Association. 1992; 87(420): 1209–1226.
Sedlmeier P, Gigerenzer G. Do studies of statistical power have an effect on the power of studies? Psychological Bulletin. 1989; 105: 309–316.
Thomas L. Retrospective power analysis. Conservation Biology. 1997; 11(1): 276–280.
Tsang R, Colley L, Lynd LD. Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials. Journal of Clinical Epidemiology. 2009; 62(6): 609–616.
Wittes J. Sample size calculations for randomized clinical trials. Epidemiologic Reviews. 2002; 24(1): 39–53.
